Kodiak Sciences (KOD)’ tabirafusp alfa was granted FDA orphan designation as a treatment of uveitic macular edema, according to a post to the agency’s website.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks